MV Capital Management Inc. Has $844,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

MV Capital Management Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,707 shares of the healthcare conglomerate’s stock after selling 44 shares during the quarter. MV Capital Management Inc.’s holdings in UnitedHealth Group were worth $844,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Tealwood Asset Management Inc. raised its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares during the last quarter. Atlas Private Wealth Advisors lifted its holdings in UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares during the period. Prentice Wealth Management LLC grew its holdings in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares during the period. Baker Avenue Asset Management LP boosted its position in shares of UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after purchasing an additional 20 shares in the last quarter. Finally, Granite Harbor Advisors Inc. increased its position in UnitedHealth Group by 2.9% in the 3rd quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock valued at $362,000 after buying an additional 20 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on UNH. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Barclays upped their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, June 28th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price on the stock in a report on Wednesday, June 5th. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Price Performance

NYSE UNH opened at $498.13 on Wednesday. The stock’s fifty day moving average price is $498.40 and its 200 day moving average price is $501.35. The company has a market cap of $458.47 billion, a price-to-earnings ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the company posted $6.26 EPS. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a $2.10 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.